The rise and fall of mood stabilizers

References

• Russell SJ, Browne JL. Staying well with bipolar disorder. Aust N Z J Psychiatry 2005; 39: 187–193
   PubMed Web of Science ®Google Scholar
• Frances A, Docherty J, Kahn D. Treatment of bipolar disorder. J Clin Psychiatry 1996; 57: 5–58
   Web of Science ®Google Scholar
• Goldney RD, Fisher LJ, Grande ED, Taylor AW, Hawthorne G. Bipolar I and II disorders in a random and representative Australian population. Aust N Z J Psychiatry 2005; 39: 726–729
   PubMed Web of Science ®Google Scholar
• Malhi GS, Mitchell PB, Salim S. Bipolar depression: management options. CNS Drugs 2003; 17: 19–25
   Web of Science ®Google Scholar
• Malhi GS, Berk M, Bourin M, et al. Atypical mood stabilisers: a ‘typical’ role for atypical antipsychotics. Acta Psychiatr Scand 2005; 111: 29–38
   PubMed Web of Science ®Google Scholar
• Bowden CL, Karren NU. Anticonvulsants in bipolar disorder. Aust N Z J Psychiatry 2006; 40: 386–393
   PubMed Web of Science ®Google Scholar
• Tohen M, Sanger T, McElroy SL, et al. Olanzapine versus placebo in the treatment of acute mania. Am J Psychiatry 1999; 156: 702–709
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Keck P, Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162: 1351–1360
   PubMed Web of Science ®Google Scholar
• Bauer MS, Mitchner L. What is a “mood stabilizer”? An evidence-based response. Am J Psychiatry 2004; 161: 3–18
   PubMed Web of Science ®Google Scholar
• Bhagwagar Z, Goodwin GM. The role of lithium in the treatment of bipolar depression. Clin Neurosci Res 2002; 2: 222–227
   Web of Science ®Google Scholar
• McGorry P. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005; 39: 1–30
   PubMed Web of Science ®Google Scholar
• Berk M, Dodd S, Malhi GS. ‘Bipolar missed states’: the diagnosis and clinical salience of bipolar mixed states. Aust N Z J Psychiatry 2005; 39: 215–221
   PubMed Web of Science ®Google Scholar
• Goldberg, JF, Kelley, ME, Rosenquist, KJ, Hsu, DJ, Filkowski, MM, Nassir Ghaemi, S. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study. J Affect Disord 2007; [ Epub ahead of print].
   Web of Science ®Google Scholar
• Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ. Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 1993; 13: 280–283
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000; 61: 841–850
   PubMed Web of Science ®Google Scholar
• Muzina DJ, Calabrese JR. Maintenance therapies in bipolar disorder: focus on randomised controlled studies. Aust N Z J Psychiatry 2005; 39: 652–661
   PubMed Web of Science ®Google Scholar
• Maggs R. Treatment of manic illness with lithium carbonate. Br J Psychiatry 1963; 109: 56–65
   Web of Science ®Google Scholar
• Calabrese JR. Lamotrigine and the treatment of bipolar disorder. Eur Neuropsychopharmacol 1999; 9: S107–108
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Shelton M, Rapport D, et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005; 162: 2152–2161
   PubMed Web of Science ®Google Scholar
• Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004; 161: 217–222
   PubMed Web of Science ®Google Scholar
• Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry 2005; 162: 1805–1819
   PubMed Web of Science ®Google Scholar
• Bowden CL, Brugger A, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994; 271: 918–924
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57: 481–489
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65: 432–441
   PubMed Web of Science ®Google Scholar
• Amann B, Grunze H, Vieta E, Trimble M. Antiepileptic drugs and mood stability. Clinical EEG Neurosci 2007; 38: 116–123
   PubMed Web of Science ®Google Scholar
• Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 2005; 86: 1–10
   PubMed Web of Science ®Google Scholar
• Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania. A systematic review and meta-analysis of randomised controlled studies. Arch Gen Psychiatry 2007; 64: 442–455
   PubMed Web of Science ®Google Scholar
• Sachs GS, Nirenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356(17)1771–1773
   PubMed Web of Science ®Google Scholar
• Goodwin, GM; Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003; 17:149–173.
   PubMed Web of Science ®Google Scholar